Enveric Biosciences Inc. (NASDAQ: ENVB) Stock Information | RedChip

Enveric Biosciences Inc. (NASDAQ: ENVB) Listen to this Section


$0.49
+0.0060 ( +1.24% ) 113.0K

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Market Data


Open


$0.49

Previous close


$0.48

Volume


113.0K

Market cap


$3.91M

Day range


$0.48 - $0.51

52 week range


$0.41 - $2.92

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
def Proxies and info statements 5 Apr 16, 2024
ars Annual reports 1 Apr 16, 2024
8-k 8K-related 13 Mar 28, 2024
8-k 8K-related 15 Mar 26, 2024
10-k Annual reports 90 Mar 26, 2024
8-k 8K-related 15 Mar 19, 2024
8-k 8K-related 21 Mar 11, 2024
8-k 8K-related 16 Feb 29, 2024
4 Insider transactions 1 Feb 26, 2024
4 Insider transactions 1 Feb 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.